Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

ASC618 Gene Therapy in Hemophilia A Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04676048
Recruitment Status : Not yet recruiting
First Posted : December 19, 2020
Last Update Posted : November 18, 2021
Information provided by (Responsible Party):
ASC Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : December 2026